Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view
β-blockers is a vast group of antiarrhythmic drugs which differ in their pharmacokinetic and chemical properties. Some of them block β-adrenergic receptors selectively while the others work non-selectively. Consequently, they reduce the influence of the sympathetic nervous system on the heart, actin...
Main Authors: | Łukasz Wołowiec, Grzegorz Grześk, Joanna Osiak, Aleksandra Wijata, Martyna Mędlewska, Patryk Gaborek, Joanna Banach, Anna Wołowiec, Mariola Głowacka |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.1043714/full |
Similar Items
-
Neuropsychiatric Consequences of Lipophilic Beta-Blockers
by: Sabina Alexandra Cojocariu, et al.
Published: (2021-02-01) -
MicroRNA and lncRNA as the Future of Pulmonary Arterial Hypertension Treatment
by: Łukasz Wołowiec, et al.
Published: (2023-06-01) -
Prognostic value of plasma secretoneurin concentration in patients with heart failure with reduced ejection fraction in one-year follow-up
by: Łukasz Wołowiec, et al.
Published: (2024-12-01) -
Safe and Effective Treatment of Intracranial Infantile Hemangiomas with Beta-Blockers
by: Aoife Naughton, et al.
Published: (2021-07-01) -
The Role of Selected Epigenetic Pathways in Cardiovascular Diseases as a Potential Therapeutic Target
by: Anna Wołowiec, et al.
Published: (2023-09-01)